| # | Drug | Count |
|---|---|---|
| 0 | ISOTRETINOIN | 92 |
| 1 | SOMATROPIN | 49 |
| 2 | TRIPTORELIN | 27 |
| 3 | ESTRADIOL | 12 |
| 4 | ESTRADIOL GEL 0.1% | 12 |
| 5 | ESTRADIOL TRANSDERMAL | 12 |
| 6 | ESTRADIOL, | 12 |
| 7 | ETOPOSIDE | 12 |
| 8 | CARBOPLATIN | 10 |
| 9 | HYDROCORTISONE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIPTORELIN | 27 | 0.0081 |
| 1 | SULFACETAMIDE SODIUM | 2 | 0.0041 |
| 2 | MECASERMIN | 2 | 0.0025 |
| 3 | DINUTUXIMAB | 2 | 0.0023 |
| 4 | ISOTRETINOIN | 92 | 0.0018 |
| 5 | VANDETANIB | 2 | 0.0011 |
| 6 | MITOTANE | 2 | 0.0011 |
| 7 | CLEAR MINT, GEL TOOTHPASTE | 1 | 0.0009 |
| 8 | SODIUM FLUORIDE F18 | 1 | 0.0009 |
| 9 | SODIUM FLUORIDE F-18 | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Retinoid [EPC] | 96 |
| 1 | Recombinant Human Growth Hormone [EPC] | 36 |
| 2 | Corticosteroid [EPC] | 19 |
| 3 | Topoisomerase Inhibitor [EPC] | 13 |
| 4 | Estrogen [EPC] | 12 |
| 5 | Platinum-based Drug [EPC] | 12 |
| 6 | Alkylating Drug [EPC] | 9 |
| 7 | Purine Antimetabolite [EPC] | 9 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 9 | Hedgehog Pathway Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 1 | Recombinant Human Growth Hormone [EPC] | 36 | 0.0016 |
| 2 | Hedgehog Pathway Inhibitor [EPC] | 6 | 0.0006 |
| 3 | Retinoid [EPC] | 96 | 0.0004 |
| 4 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Topoisomerase Inhibitor [EPC] | 13 | 0.0002 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 7 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 8 | Vitamin K [EPC] | 1 | 0.0001 |
| 9 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |